Ocugen Inc Equity-NMS: OCGN

$- -1.2 (January 1, 1970)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$1.2
Open :$1.17
Today's high :$1.17
Today's low :$1.14
52W low :$0.515
52W high :$1.979
EPS(TTM): :-0.21
Shares O/S :292.03 M
Market cap :332.92 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Ocugen Inc $- -0% - 332.92M

Frequently Asked Questions

What is the share price of Ocugen Inc today?

Ocugen Inc (OCGN) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Ocugen Inc

Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. Its technology pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. It is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. It is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.